N
Natixis Portfolio holdings
AUM
$20.1B
1-Year Return
17.51%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Quarter Return
+7.66%
1 Year Return
+17.51%
3 Year Return
+106.1%
5 Year Return
+162.29%
10 Year Return
+380.38%
AUM
$17B
AUM Growth
-$4.09B
(-19%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-13.91%
Top 10 Holdings %
Top 10 Hldgs %
25.72%
Holding
1,313
New
332
Increased
348
Reduced
298
Closed
301
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$952M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
+$388M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$228M |
| 4 |
PepsiCo
PEP
|
+$207M |
| 5 |
Energy Transfer Partners
ET
|
+$182M |
Top Sells
| 1 |
Tesla
TSLA
|
+$2.21B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$331M |
| 3 |
Bank of America
BAC
|
+$290M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$263M |
| 5 |
JPMorgan Chase
JPM
|
+$252M |
Sector Composition
| 1 | Technology | 23.03% |
| 2 | Healthcare | 11.88% |
| 3 | Energy | 8.97% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Arqit Quantum
ARQQ
$420M
| $72.2K | ﹤0.01% |
+800
| New | +$72.2K |
|
|
NUVA
827
DELISTED
NuVasive, Inc.
NUVA
| $68.5K | ﹤0.01% |
+1,660
| New | +$68.5K |
|
828
W.W. Grainger
GWW
$47.5B
| $66.2K | ﹤0.01% |
119
-2,669
| -96% | -$1.48M |
|
829
Xoma
XOMA
$439M
| $65.8K | ﹤0.01% |
+3,576
| New | +$65.8K |
|
830
Expeditors International
EXPD
$16.4B
| $65.4K | ﹤0.01% |
629
-10,640
| -94% | -$1.11M |
|
831
Eversource Energy
ES
$23.8B
| $63.9K | ﹤0.01% |
762
-59,904
| -99% | -$5.02M |
|
832
Canadian Imperial Bank of Commerce
CM
$72.6B
| $62.7K | ﹤0.01% |
1,549
-26,530
| -94% | -$1.07M |
|
833
Teva Pharmaceuticals
TEVA
$22.6B
| $60.8K | ﹤0.01% |
+6,665
| New | +$60.8K |
|
834
Calix
CALX
$4B
| $60.4K | ﹤0.01% |
+883
| New | +$60.4K |
|
835
Exelixis
EXEL
$10.2B
| $59.4K | ﹤0.01% |
+3,705
| New | +$59.4K |
|
836
CorVel
CRVL
$4.47B
| $58.9K | ﹤0.01% |
+1,215
| New | +$58.9K |
|
837
Udemy
UDMY
$1.03B
| $58.8K | ﹤0.01% |
5,576
| – | – |
|
838
JetBlue
JBLU
$1.87B
| $58.2K | ﹤0.01% |
8,979
-168,723
| -95% | -$1.09M |
|
839
Brown-Forman Class A
BF.A
$13.2B
| $57.5K | ﹤0.01% |
874
+501
| +134% | +$32.9K |
|
|
SLI
840
Standard Lithium
SLI
$569M
| $57.2K | ﹤0.01% |
+19,400
| New | +$57.2K |
|
|
BCTX
841
Briacell Therapeutics
BCTX
$13.9M
| $56.3K | ﹤0.01% |
+83
| New | +$56.3K |
|
842
Petrobras
PBR
$79.8B
| $55.9K | ﹤0.01% |
+5,249
| New | +$55.9K |
|
843
Lightbridge
LTBR
$376M
| $55.6K | ﹤0.01% |
14,285
| – | – |
|
844
BioCryst Pharmaceuticals
BCRX
$1.69B
| $55.5K | ﹤0.01% |
+4,834
| New | +$55.5K |
|
845
The GEO Group
GEO
$3.05B
| $54.8K | ﹤0.01% |
+5,000
| New | +$54.8K |
|
846
Arvinas
ARVN
$587M
| $54.5K | ﹤0.01% |
+1,592
| New | +$54.5K |
|
|
PRTK
847
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $54.2K | ﹤0.01% |
+29,006
| New | +$54.2K |
|
848
Shake Shack
SHAK
$3.93B
| $52.6K | ﹤0.01% |
+1,267
| New | +$52.6K |
|
849
Vail Resorts
MTN
$5.48B
| $51.7K | ﹤0.01% |
+217
| New | +$51.7K |
|
|
ICPT
850
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $49.5K | ﹤0.01% |
+3,998
| New | +$49.5K |
|